TUMOR INFILTRATING LYMPHOCYTES AS AN INDEPENDENT PROGNOSTIC FACTOR IN TRANSITIONAL CELL BLADDER-CANCER

被引:109
作者
LIPPONEN, PK
ESKELINEN, MJ
JAUHIAINEN, K
HARJU, E
TERHO, R
机构
[1] UNIV KUOPIO, DEPT SURG, SF-70211 KUOPIO, FINLAND
[2] MIKKELI CENT HOSP, DEPT SURG, MIKKELI, FINLAND
[3] JYVASKYLA CENT HOSP, DEPT SURG, JYVASKYLA, FINLAND
[4] SAVONLINNA CENT HOSP, DEPT SURG, SAVONLINNA, FINLAND
关键词
D O I
10.1016/0959-8049(93)90579-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of tumour infiltrating lymphocytes (TIL) was assessed in a cohort of 514 patients with a transitional cell bladder cancer (TCC) during a follow up period of over 9 years. The density of TIL were positively correlated to WHO grade (P < 0.0001), non-papillary growth architecture (P < 0.0001), morphometric nuclear factors (P < 0.007) and volume corrected mitotic index (MN index) (P < 0.0001). Dense TIL predicted progression in Ta-T1 tumours (P < 0.0006) whereas in a multivariate analysis they had no independent predictive value. Dense TIL were related to short recurrence-free survival in Ta-T1 tumours in a univariate analysis (P = 0.06) as well as in a multivariate analysis (P = 0.005). Dense TIL predicted unfavourable prognosis in the entire cohort (P = 0.0316) and in papillary tumours (P = 0.062) whereas in nodular tumours TIL were a sign of good prognosis (P = 0.0141). Also in T3-T4 tumours TIL were related to less aggressive behaviour of TCC (P = 0.0259). In a multivariate analysis including clinical stage (T-category), WHO grade, papillary status, six morphometric nuclear factors and MN index dense TIL were a highly significant indicator of a favourable prognosis (P = 0.007). Particularly TIL categorised rapidly proliferating TCC into prognostic groups (P = 0.001). The results show that TIL are a sign of efficient host defence mechanisms in TCC and TIL predict a favourable prognosis in invasive TCC.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 36 条
  • [1] LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER
    AALTOMAA, S
    LIPPONEN, P
    ESKELINEN, M
    KOSMA, VM
    MARIN, S
    ALHAVA, E
    SYRJANEN, K
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 859 - 864
  • [2] COMPARISON OF QUANTITATIVE AND CLASSIC PROGNOSTICATORS IN URINARY-BLADDER CARCINOMA - A MULTIVARIATE-ANALYSIS OF DNA FLOW CYTOMETRIC, NUCLEAR MORPHOMETRIC AND CLINICOPATHOLOGICAL FEATURES
    BLOMJOUS, CEM
    SCHIPPER, NW
    VOS, W
    BAAK, JPA
    DEVOOGT, HJ
    MEIJER, CJLM
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1989, 415 (05) : 421 - 428
  • [3] EFFECTS OF LOCAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH BLADDER-CARCINOMA ON IMMUNOCOMPETENT CELLS OF THE BLADDER WALL
    BOHLE, A
    GERDES, J
    ULMER, AJ
    HOFSTETTER, AG
    FLAD, HD
    [J]. JOURNAL OF UROLOGY, 1990, 144 (01) : 53 - 58
  • [4] IMMUNE RESPONSE TO URINARY BLADDER TUMOURS IN MAN
    BUBENIK, J
    PERLMANN, P
    HELMSTEIN, K
    MOBERGER, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1970, 5 (01) : 39 - +
  • [5] CHAUHAN SS, 1991, ANCER RES, V51, P1478
  • [6] MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION
    CLARK, WH
    ELDER, DE
    GUERRY, D
    BRAITMAN, LE
    TROCK, BJ
    SCHULTZ, D
    SYNNESTVEDT, M
    HALPERN, AC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24): : 1893 - 1904
  • [7] COX DR, 1972, J R STAT SOC B, V34, P187
  • [8] PRESENCE OF ACTIVATED T-CELLS WITH A T8+ M1+ LEU 7+ SURFACE PHENOTYPE IN INVADED LYMPH-NODES FROM PATIENTS WITH SOLID TUMORS
    COZZOLINO, F
    TORCIA, M
    CASTIGLI, E
    SELLI, C
    GIORDANI, R
    CAROSSINO, AM
    SQUADRELLI, M
    CAGNONI, M
    PISTOIA, V
    FERRARINI, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 77 (03): : 637 - 641
  • [9] PRODUCTION OF PROSTAGLANDIN-E2 BY BLADDER-TUMOR CELLS IN TISSUE-CULTURE AND A POSSIBLE MECHANISM OF LYMPHOCYTE INHIBITION
    DROLLER, MJ
    LINDGREN, JA
    CLAESSEN, HE
    PERLMANN, P
    [J]. CELLULAR IMMUNOLOGY, 1979, 47 (02) : 261 - 273
  • [10] FURUKAWA T, 1985, CANCER, V56, P2651, DOI 10.1002/1097-0142(19851201)56:11<2651::AID-CNCR2820561120>3.0.CO